Related Experiment Video
Updated: Jul 5, 2026
09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Opposing Estrous Cycle-Dependent Norepinephrine and Dopamine Regulation in Response to Methamphetamine
Rohan V Bhimani1,2, Ryan C Pauly1, Elizabeth G Mietlicki-Baase2,3,4
1Department of Biotechnical and Clinical Laboratory Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
Journal of Neurochemistry
|July 4, 2026
Summary
Estrous cycle stage significantly impacts norepinephrine and dopamine levels in rat brain regions, affecting responses to methamphetamine. These findings highlight sex-specific catecholamine dynamics crucial for understanding behavior and developing targeted therapies.
Area of Science:
- Neuroscience
- Neuropharmacology
- Behavioral Science
Background:
- Central catecholamine systems (norepinephrine and dopamine) are vital for survival behaviors.
- Limbic areas like the nucleus accumbens (NAc) and bed nucleus of the stria terminalis (BNST) are key targets for stimulant drugs.
- Sex differences and estrous cycle stages may distinctly regulate catecholamine transmission, but this is not well understood.
Purpose of the Study:
- To investigate estrous cycle-dependent changes in catecholamine regulation in the BNST and NAc of rats.
- To determine how methamphetamine (METH) affects norepinephrine and dopamine transmission in these brain regions in males and females across the estrous cycle.
Main Methods:
- In vivo fast-scan cyclic voltammetry was used in anesthetized male and female rats.
- Catecholamine regulation was assessed via transporters and autoreceptors in the BNST and NAc.
- The impact of METH on norepinephrine and dopamine transmission was evaluated.
Main Results:
- Methamphetamine increased norepinephrine in the BNST most during non-estrus stages (diestrus/proestrus).
- Dopamine release in the NAc, stimulated electrically or by METH, was heightened during estrus.
- Estrous cycle stage significantly modulated limbic norepinephrine and dopamine dynamics.
Conclusions:
- Estrous cycle stage critically influences catecholamine transmission in the BNST and NAc.
- These findings provide novel insights into sex-specific regulation of brain catecholamine systems.
- This research offers a framework for developing sex-specific therapies for conditions like drug use disorders and obesity.
Related Concept Videos
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:28Adrenergic Agonists: Mixed-Action Agents
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...